Your browser doesn't support javascript.
loading
RNA sequencing and Immunohistochemistry Reveal ZFN7 as a Stronger Marker of Survival than Molecular Subtypes in G-CIMP-negative Glioblastoma.
Esteve-Codina, Anna; Alameda, Francesc; Carrato, Cristina; Pineda, Estela; Arpí, Oriol; Martinez-García, Maria; Mallo, Mar; Gut, Marta; Dabad, Marc; Tortosa, Avelina; Del Barco, Sonia; Capellades, Jaume; Puig, Josep; Gallego, Oscar; Pujol, Teresa; Oleaga, Laura; Gil-Gil, Miquel; de Quintana-Schmidt, Cristian; Valduvieco, Izaskun; Martinez-Cardús, Anna; Bellosillo, Beatriz; Muñoz-Marmol, Ana Maria; Esteve, Anna; Domenech, Marta; Camins, Angels; Craven-Bartle, Jordi; Villa, Salvador; Marruecos, Jordi; Domenech, Sira; de la Iglesia, Nuria; Balana, Carmen.
Afiliación
  • Esteve-Codina A; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Alameda F; Pathology Department, Neuropathology Unit, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Carrato C; Pathology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Pineda E; Medical Oncology, Hospital Clínic, Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Arpí O; Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Martinez-García M; Medical Oncology, Hospital del Mar, Barcelona, Spain.
  • Mallo M; Institut de Recerca Contra la Leucèmia Josep Carreras, Badalona, Spain.
  • Gut M; CNAG-CRG, Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Dabad M; CNAG-CRG, Centre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Tortosa A; Laboratori de Quimio-resistència i Cáncer, School of Medicine and Health Sciences, University of Barcelona, Department of Fundamental Care and Medical-Surgical Nursing, Bellvitge Biomedical Research Institute (IDIBELL), Bellvitge, Spain.
  • Del Barco S; Medical Oncology, Institut Catala d'Oncologia (ICO), Hospital Josep Trueta, Girona, Spain.
  • Capellades J; Radiology Department, Hospital del Mar, Barcelona, Spain.
  • Puig J; Radiology Department, Institut de Diagnòstic per la Imatge, Hospital Josep Trueta, Girona, Spain.
  • Gallego O; Medical Oncology, Hospital de Sant Pau, Barcelona, Spain.
  • Pujol T; Radiology Department, Hospital Clínic, Barcelona, Spain.
  • Oleaga L; Radiology Department, Hospital Clínic, Barcelona, Spain.
  • Gil-Gil M; Neuro-Oncology Unit & Medical Oncology Department, Institut Catala d'Oncologia (ICO), Institut de Investigació Bellvitge (IDIBELL), L'Hospitalet, Barcelona, Spain.
  • de Quintana-Schmidt C; Neurosurgery Department, Hospital de Sant Pau, Barcelona, Spain.
  • Valduvieco I; Radiation Therapy Department, Hospital Clínic, Barcelona, Spain.
  • Martinez-Cardús A; Institut Catala d'Oncologia (ICO), Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Bellosillo B; Pathology Department, Neuropathology Unit, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Muñoz-Marmol AM; Pathology Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Esteve A; Institut Catala d'Oncologia (ICO), Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Domenech M; Institut Catala d'Oncologia (ICO), Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain.
  • Camins A; Radiology Department, Institut de Diagnòstic per la Imatge, Hospital de Bellvitge, Bellvitge, Spain.
  • Craven-Bartle J; Radiation Therapy Department, Hospital de Sant Pau, Barcelona, Spain.
  • Villa S; Radiation Therapy Department, Institut Catala d'Oncologia (ICO), Badalona, Spain.
  • Marruecos J; Radiation Oncology Department, Institut Catala d'Oncologia (ICO), Girona, Spain.
  • Domenech S; Radiology Department, Institut de Diagnòstic per la Imatge, Hospital Germans Trias i Pujol, Badalona, Spain.
  • de la Iglesia N; Glioma and Neural Stem Cell Group, Translational Genomics and Targeted Therapeutics in Solid Tumors Team, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
  • Balana C; Institut Catala d'Oncologia (ICO), Badalona Applied Research Group in Oncology (B-ARGO Group), Institut Investigació Germans Trias i Pujol (IGTP), Badalona, Spain. cbalana@iconcologia.net.
Clin Cancer Res ; 27(2): 645-655, 2021 01 15.
Article en En | MEDLINE | ID: mdl-33106291
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Inmunohistoquímica / Biomarcadores de Tumor / Análisis de Secuencia de ARN / Glioblastoma / Factores de Transcripción de Tipo Kruppel Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Inmunohistoquímica / Biomarcadores de Tumor / Análisis de Secuencia de ARN / Glioblastoma / Factores de Transcripción de Tipo Kruppel Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos